{"id":"etodolac-lidocaine-topical-patch","safety":{"commonSideEffects":[{"rate":null,"effect":"Application site irritation or erythema"},{"rate":null,"effect":"Pruritus at application site"},{"rate":null,"effect":"Contact dermatitis"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Etodolac is a selective COX-2 inhibitor that reduces prostaglandin synthesis and inflammation at the site of application. Lidocaine is a local anesthetic that blocks sodium channels and provides rapid pain relief. The combination patch allows both agents to penetrate the skin and provide localized analgesic and anti-inflammatory effects without systemic absorption.","oneSentence":"Etodolac-lidocaine topical patch delivers a nonsteroidal anti-inflammatory drug (NSAID) and local anesthetic directly to affected tissue to reduce pain and inflammation.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:11:45.109Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Localized musculoskeletal pain and inflammation"},{"name":"Osteoarthritis pain (localized)"}]},"trialDetails":[{"nctId":"NCT01198834","phase":"PHASE3","title":"MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Ankle Sprains","status":"COMPLETED","sponsor":"MEDRx USA, Inc.","startDate":"2010-09","conditions":"Ankle Sprains","enrollment":600},{"nctId":"NCT01968005","phase":"PHASE3","title":"Etodolac-Lidocaine Patch in the Treatment of Acute Low Back Pain","status":"COMPLETED","sponsor":"MEDRx USA, Inc.","startDate":"2013-11","conditions":"Low Back Pain","enrollment":232},{"nctId":"NCT01161615","phase":"PHASE3","title":"MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder","status":"COMPLETED","sponsor":"MEDRx USA, Inc.","startDate":"2010-07","conditions":"Acute Tendonitis, Bursitis","enrollment":350},{"nctId":"NCT02695381","phase":"PHASE3","title":"Etodolac-lidocaine Patch in Subjects Experiencing Acute Delayed Onset Muscle Soreness","status":"COMPLETED","sponsor":"MEDRx USA, Inc.","startDate":"2016-03","conditions":"Acute Delayed Onset Muscle Soreness (DOMS)","enrollment":100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":58,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Etoreat"],"phase":"phase_3","status":"active","brandName":"Etodolac-lidocaine topical patch","genericName":"Etodolac-lidocaine topical patch","companyName":"MEDRx USA, Inc.","companyId":"medrx-usa-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Etodolac-lidocaine topical patch delivers a nonsteroidal anti-inflammatory drug (NSAID) and local anesthetic directly to affected tissue to reduce pain and inflammation. Used for Localized musculoskeletal pain and inflammation, Osteoarthritis pain (localized).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}